
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
NFAT5 CRISPR/Cas9 KO Plasmid (h) | sc-401359 | 20 µg | $397.00 |
NFAT5 (nuclear factor of activated T cells 5), also known as TonEBP, is a Rel-family transcription factor that coordinates cellular adaptation to hypertonic stress by regulating osmoprotective gene programs, including transporters and enzymes involved in compatible osmolyte accumulation. In immune and epithelial contexts, NFAT5 influences cytokine production, macrophage polarization, and lymphocyte function, linking osmotic sensing to inflammatory signaling and cellular survival pathways. NFAT5 activity intersects with MAPK and calcium-dependent signaling networks and helps maintain protein homeostasis and cell volume control under stress. Dysregulated NFAT5 signaling has been associated with inflammatory disorders, renal medullary physiology, and tumor microenvironment stress responses, making it relevant for mechanistic studies of stress adaptation and immune regulation.
NFAT5 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the NFAT5 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the NFAT5 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the NFAT5 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish NFAT5 protein expression.
This CRISPR knockout system enables efficient generation of NFAT5-deficient cell models for investigation of NFAT5 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.